Manage cookies
We use cookies to provide the best site experience.
Manage cookies
Cookie Settings
Cookies necessary for the correct operation of the site are always enabled.
Other cookies are configurable.
Essential cookies
Always On. These cookies are essential so that you can use the website and use its functions. They cannot be turned off. They're set in response to requests made by you, such as setting your privacy preferences, logging in or filling in forms.
Analytics cookies
Disabled
These cookies collect information to help us understand how our Websites are being used or how effective our marketing campaigns are, or to help us customise our Websites for you. See a list of the analytics cookies we use here.
Advertising cookies
Disabled
These cookies provide advertising companies with information about your online activity to help them deliver more relevant online advertising to you or to limit how many times you see an ad. This information may be shared with other advertising companies. See a list of the advertising cookies we use here.
Key Topics 2026
Key Topics 2026
Key Topics 2026
Key Topics 2026
Key Topics 2026
Key Topics 2026
Pre-Forum Day, January 26
19:00
19:00

Welcome Reception & Networking

Day 1, January 27
08:00 – 09:00
08:00 – 09:00
Participant Registration.
Morning Coffee & Networking
09:00 – 09:10
09:00 – 09:10
Forum Opening.
Welcome Address by Organizers
09:10 – 10:10
09:10 – 10:10
Plenary Discussion:
Eurasian Pharma Market – Industry Perspectives on Challenges and Opportunities
  • EAEU pharma market: Growth, barriers, and prospects
  • Production localization: Incentives, challenges, success stories
  • Impact of regulatory requirements on business strategies
  • Liberalization of public procurement: New opportunities for business
  • Implementation of e-document flow and product marking
  • Moderator:
    VYACHESLAV LOKSHIN

    President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
10:10 – 10:30
10:10 – 10:30
Coffee Break & Networking
10:30 – 11:50
10:30 – 11:50
Plenary Session:
State and Business – Creating Conditions for Industry Growth
  • Legislative updates: New registration rules, GMP inspections, clinical trials
  • Harmonization of EAEU requirements: Progress and next steps
  • Support for localization and innovation: Government incentives
  • Plans to improve the pharmaceutical investment climate
  • Medicine supply in CIS countries: Draft model law discussion
11:50 – 12:10
11:50 – 12:10
Coffee Break & Networking
12:10 – 13:30
12:10 – 13:30
Panel Session:
The Future of Drug Registration in the Eurasian Region
  • Progress in unifying EAEU registration rules
  • Uzbekistan’s experience: Steps toward EAEU alignment
  • How unified standards reduce registration timelines
  • Key remaining regulatory barriers
  • Fast-track procedures for innovative and orphan drugs
  • EAEU pharmacopoeia standards: Recent changes and quality impact
  • Implications for API supply chains
  • Harmonized procedures and market entry simplification
13:30 – 13:50
13:30 – 13:50
Coffee Break & Networking
13:50 – 15:00
13:50 – 15:00
Panel Session:
Pricing and Economic Efficiency in Pharma
  • Comparative pricing models in EAEU/CIS: Fixed prices, tenders, reference pricing
  • Funding mechanisms for high-cost therapies in EAEU
  • Reference country selection challenges
  • Feasibility of unified registration/pricing in the Union
  • National regulation vs. deregulation: Harmonizing approaches
  • Balancing patient, state, and business interests
  • HTA impact: How efficacy assessments shape procurement
  • Medicine procurement: Supply chain management
15:00 – 15:40
15:00 – 15:40
Lunch Break
15:40 – 16:50
15:40 – 16:50
Panel Session:
Modern IP Protection & Management in Pharma
  • Generic launch strategies pre-patent expiry
  • Clinical/preclinical data protection: Country-specific nuances
  • "Insufficient use of invention" criteria in litigation
  • Compulsory licensing practices in EAEU
  • Patenting innovative drugs: Key considerations
  • Eurasian Pharmaceutical Register operations
  • Data exclusivity: Global vs. local practices
  • Parallel imports: Risks and opportunities
  • Counterfeits and copycats
16:50 – 17:10
16:50 – 17:10
Coffee Break & Networking
17:10 – 18:10
17:10 – 18:10
Real-World Data (RWD) in Pharma: From Collection to Decision-Making
  • Regulatory requirements for RWD collection/analysis
  • Leveraging RWD for early market access
  • Data sources: EHRs, patient registries, wearables, social media
  • AI and big data in RWD processing
  • Personalized medicine: Data-driven therapy selection
  • Challenges: Data quality, privacy, regulatory constraints
18:10
18:10
Day 1 Closing. Evening Reception & Informal Networking
Day 2, January 28
08:30 – 09:00
08:30 – 09:00
Morning Coffee & Networking
09:00 – 10:20
09:00 – 10:20
Expert Analytical Panel
  • Latest sales volumes, growth rates, and market share breakdowns (generics, innovative drugs, OTC, biologics) in EAEU countries and Uzbekistan
  • 2026 forecasts: Which markets will show the highest growth?
  • Comparison with global trends: How does the EAEU perform against other regions?
  • Which drug categories lead in demand growth?
  • Impact of inflation, exchange rate fluctuations, and budget constraints on the market
  • Transformation of consumer preferences: New pharmaceutical demand trends in the EAEU
  • Key challenges and opportunities for pharma businesses in the region
  • How will the pharmaceutical landscape evolve in 10 years? Promising developments and new drugs
10:20 – 10:40
10:20 – 10:40
Coffee Break & Networking
10:40 – 12:00
10:40 – 12:00
Panel Session:
National Pharmaceutical R&D Projects – Integrating Science, Production, and International Partnerships
  • R&D: The search for new molecules
  • Government support priorities: Public procurement, simplified product certification
  • Funding mechanisms and support for scientific research
  • Collaboration between government institutions, businesses, and academia
  • Successful examples of joint projects with international partners
  • Creating conditions to retain highly qualified professionals in the industry
  • National drug security: Strategies for resilience and self-sufficiency
  • Accelerating the scaling of lab technologies to GMP production
  • Localization of biopharmaceutical production
12:00 – 12:20
12:00 – 12:20
Coffee Break & Networking
12:20 - 13:50
12:20 - 13:50
Panel Session:
Commercialization of Pharmaceutical Products – Marketing & Digital Technologies
  • Integrating online and offline channels to enhance customer engagement
  • Leveraging Big Data, analytics, and AI for personalized communications
  • Content marketing, social media, mobile apps, and e-commerce
  • Restrictions on drug advertising and consumer communications
  • Personalized engagement with doctors and pharmacies
  • Sales automation via CRM and medical representative platforms
  • Compliance with data protection laws when handling patient data
13:50 - 14:30
13:50 - 14:30
Lunch Break
14:30 - 15:40
14:30 - 15:40
From Factory to Patient: Optimizing Pharma Supply Chains in the New Reality
  • Analysis of current and future transport corridors
  • Use of temporary storage warehouses, cold chains, and simplified customs clearance
  • Practical challenges and solutions in implementing marking systems
  • Product marking as a tool for transparency, anti-counterfeiting, and improved customer experience
  • Digital platforms for order and supply management
  • Collaboration between manufacturers, distributors, and pharmacy networks
15:40 - 16:00
15:40 - 16:00
Coffee Break & Networking
16:00 – 17:00
16:00 – 17:00
Parallel sessions
17:00
17:00
Discussion & Resolution Signing. Cocktail Reception
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
For any questions regarding participation, partnership, or registration, please reach out to our team: